Skip to content
Govbase
Govbase
Presidential·Exec Order

Trump Orders DOJ to Fast-Track Marijuana Rescheduling to Schedule III

Increasing Medical Marijuana and Cannabidiol Research

3 months ago·View on Federal Register

Key Points

  • The President is directing the Department of Justice to quickly finish moving marijuana from the most restrictive drug category to a lower one called Schedule III. This change recognizes that marijuana has accepted medical uses, such as treating chronic pain and nausea, and makes it much easier for scientists to study its benefits and risks.
  • The order aims to help the more than 6 million Americans who already use medical marijuana across 40 states. Currently, strict federal rules make it hard for doctors to give clear advice on how to use it safely. New research will help healthcare providers understand the right dosages and how marijuana might react with other medications.
  • Government agencies like the FDA and the National Institutes of Health will create new ways to study how people use marijuana and CBD in their daily lives. This research will focus on how these products affect specific groups, including seniors who use them for pain relief and young adults who may face different long-term health effects.
  • The White House will work with Congress to update rules for hemp-derived CBD products. The goal is to create a better system for labeling these products and setting limits on how much THC they can contain. This ensures that people buying CBD for health reasons are getting safe, accurately labeled products.
HealthcareCriminal JusticeAgriculture

Impact Analysis

Personal Impact

Scores: 1 = low, 5 = highSentiment: -5 to +5 (net benefit)

What Happens Next

Projected impacts based on AI analysis

Attorney General begins expediting the marijuana rescheduling rulemaking process, including the pending administrative law hearing

The legal process to move marijuana from Schedule I to Schedule III gets fast-tracked, but the hearing and final rule could still take months to over a year to complete

Federal agencies begin developing research frameworks for medical marijuana and CBD products

HHS, FDA, CMS, and NIH start building new ways to study real-world marijuana and CBD use, which will eventually lead to better medical guidance for patients and doctors

1 Article

news_articleCenter

Where Is Cannabis Legal? A Guide To All 50 States

Source Information

Signed By

Document Type

Executive Order

Official Title

Increasing Medical Marijuana and Cannabidiol Research

Analysis generated by AI. Always verify with official sources.